Authors' Reply to Lechat et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"

Clin Pharmacokinet. 2019 Oct;58(10):1353-1354. doi: 10.1007/s40262-019-00815-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Drug Compounding
  • Humans
  • Thyroxine*

Substances

  • Thyroxine